Chemistry:Alalevonadifloxacin
From HandWiki
Alalevonadifloxacin (trade name Emrok O) is an antibiotic of the fluoroquinolone class.[1] It is a prodrug of levonadifloxacin with increased oral bioavailability.[2] In India, it is approved for the treatment of infections with Gram-positive bacteria.[3]
References
- ↑ "Treatment challenges in the management of difficult-to-treat gram-positive infections: A consensus view apropos therapeutic role of novel anti-MRSA antibiotics, levonadifloxacin (IV) and alalevonadifloxacin (oral)". Indian Journal of Medical Microbiology 47. 2024. doi:10.1016/j.ijmmb.2024.100528. PMID 38228227.
- ↑ "Design and synthesis of an oral prodrug alalevonadifloxacin for the treatment of MRSA infection". Bioorganic & Medicinal Chemistry Letters 54. December 2021. doi:10.1016/j.bmcl.2021.128432. PMID 34757217.
- ↑ "Alalevonadifloxacin". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800038027.
 |  |
